Search MapQuest

Mitotherapeutix LLC

400 Farmington Ave

Farmington, CT 06032

Mitotherapeutix LLC is a biotechnology company based in Farmington, CT, specializing in mitochondrial therapy research and development.

With a focus on innovative approaches to treating mitochondrial disorders, Mitotherapeutix LLC is dedicated to advancing the field of mitochondrial medicine through cutting-edge technology and scientific expertise.

Generated from their business information

Also at this address

CytoVeris

Bioarray Genetics, Inc

Nanoionix, LLC

Lipid Genomics Inc

Own this business?

Claim it

See a problem?

You might also like

Quercus Molecular Design, LLC

Quercus Molecular Design, LLC is a research and development company based in Farmington, CT, specializing in molecular design and innovation. With a focus on cutting-edge technologies and scientific expertise, Quercus Molecular Design, LLC works to create novel solutions for various industries through its research initiatives. Generated from their business information

Encapsulate

Encapsulate is a cutting-edge biotechnology company based in Farmington, CT, specializing in innovative approaches and advanced technologies for pharmaceutical research and development, as well as for oncologists and patients dealing with colorectal, pancreatic, breast, and lung cancers. With a strong focus on delivering effective solutions, Encapsulate is dedicated to revolutionizing the field of cancer treatment through their expertise in encapsulation technology and their commitment to improving patient outcomes.Generated from the website

QCDX LLC

QCDx LLC is a medical company based in Farmington, CT, dedicated to providing innovative solutions for the detection and profiling of rare cells in the bloodstream. Their advanced technology, the RareScope system, allows for enrichment-free profiling and isolation of rare circulating tumor cells (CTCs) through 3-D optical tomography, enabling real-time cancer intelligence and precision diagnosis. With a focus on improving patient outcomes and quality of life, QCDx aims to optimize treatment, monitor therapy, characterize metastasis, and assess treatment toxicity. Utilizing their novel MultiFluor multiplex immunofluorescent probes, QCDx's RareScope platform offers rapid CTC profiling with 12 biomarkers in intact live cells, providing personalized and real-time intelligence on treatment-specific markers. This technology has applications in cancer diagnostics, cancer research, and the pharmaceutical industry, supporting all stages of drug discovery and clinical trials. With the ability to visualize cells morphologically intact and live, QCDx's RareScope system offers enrichment-free rare cell detection, deep characterization, single-cell isolation, and 3D-culture of cells under continual visualization.Generated from the website

United States›Connecticut›Farmington›Mitotherapeutix LLC

Get directions
MapQuest Travel
Route Planner
Print your map
Get help
Search the web
Send feedback

Learn more about our mobile apps.

Enterprise solutions
Claim your business
Developer resources

Jobs
Advertise with us

Terms of use
Privacy policy
Data and licenses
About our ads
Do not sell